Molecular and cellular heterogeneity: the hallmark of glioblastoma.
about
Protein interacting with C kinase 1 suppresses invasion and anchorage-independent growth of astrocytic tumor cellsGlioblastoma Stem-Like Cells: Characteristics, Microenvironment, and TherapyPre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastomaIntratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastomaDiagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.FGFR-TACC gene fusions in human glioma.Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma.Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.In reply: Reoperation for recurrent high-grade glioma: does tumor genetics play a role?Clinical significance of pre-surgical serum lipid levels in patients with glioblastoma.Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastomas.Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The φ-Index.Focused Ultrasound-enabled Brain Tumor Liquid Biopsy.Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1.Stereotactic image-based histological analysis reveals a correlation between 11C-methionine uptake and MGMT promoter methylation in non-enhancing gliomas.
P2860
Q27305818-47DB61BD-ABE7-41AF-A679-C95D2D7FA70AQ28079663-A7131A43-760F-47F6-9ADF-947FB652E1E6Q35765180-CFA447AF-000B-4650-BCF2-C4B193257179Q36082516-E08ACF64-DE4D-4B90-B69D-2AC3C07DCD26Q37641470-1F062803-23CF-4D8E-95C6-EC8CA9A07359Q38743138-AB01F079-7E37-4B51-AD48-78323935144FQ38799782-F88305C0-8C02-42F6-ADA0-23469514C421Q39010445-F61B26F4-808B-441B-B360-5C4C4586E099Q39243060-C8DD9915-86A8-4512-BE7A-598A36100E6CQ41789674-C10AB159-E303-44B6-959E-5271B84A29CCQ42821853-FFF620C1-5A59-4221-A0D3-E33E0934D6D8Q46192049-05AD5DE1-DB8D-42CC-B89B-9A8338386BD8Q47118254-1BDA4950-AB40-485B-B52B-F3F6354B600AQ47304287-69E4D359-A03F-4116-A0CD-274496FACBC5Q50055177-C20C96A5-7657-472B-A5A1-E3FD4682C502Q50130464-83A5EC49-48B3-45DC-AF38-2D750153DAD8Q52097937-BA94D3EF-FF1F-44A1-A660-D36C14759E35Q52560196-8F6DD278-BDC7-44DB-B4DC-537F7BD6B8ECQ55336403-A5846B53-AFFD-4996-9C86-5A60C7BCAA19Q55693144-19BD165D-72F6-463B-9A9C-46EBFDF802DA
P2860
Molecular and cellular heterogeneity: the hallmark of glioblastoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Molecular and cellular heterogeneity: the hallmark of glioblastoma.
@en
type
label
Molecular and cellular heterogeneity: the hallmark of glioblastoma.
@en
prefLabel
Molecular and cellular heterogeneity: the hallmark of glioblastoma.
@en
P2093
P1433
P1476
Molecular and cellular heterogeneity: the hallmark of glioblastoma.
@en
P2093
Albert H Kim
David H Kim
Diane J Aum
Eric C Leuthardt
Gavin P Dunn
Thomas L Beaumont
P356
10.3171/2014.9.FOCUS14521
P577
2014-12-01T00:00:00Z